|
|||||
|
|
A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes |
|
| Authors: | Lewis E. Holmes Rohan Gupta Saissan Rajendran John Luu John K. French Craig P. Juergens |
| Affiliation: | 1. South Western Sydney Clinical School, The University of New South Wales, Sydney, NSW, Australia;2. Cardiology Department, Liverpool Hospital, Sydney, NSW, Australia |
| Abstract: | |
| Keywords: | Abciximab Acute coronary syndrome Eptifibatide Glycoprotein IIbIIIa antagonist Percutaneous coronary intervention Tirofiban |